Prostate Cancer Diagnoses Decline From 2011 to 2013

Share this content:
From 2011 to 2013 there was a decrease in prostate cancer (PC) diagnoses, especially for younger men and low-risk disease.
From 2011 to 2013 there was a decrease in prostate cancer (PC) diagnoses, especially for younger men and low-risk disease.

(HealthDay News) -- From 2011 to 2013 there was a decrease in prostate cancer (PC) diagnoses, especially for younger men and low-risk disease, according to a research letter published online in JAMA Oncology.

Matthew J. Maurice, M.D., from the Cleveland Clinic, and colleagues identified incident cases of clinically localized PC from 2010 to 2013 to assess current diagnosis and management trends.

The researchers observed a decrease in prostate cancer diagnoses, from a high of 90,419 cases in 2011 to a low of 71,945 cases in 2013. The decrease was seen for all age and risk groups, but was greatest for men younger than 70 years (21 percent decline) and for low-risk disease (36 percent decline).

For men of all ages, especially those younger than 70 years, low- and high-risk PC diagnoses decreased significantly over time. There was a significant increase in active surveillance and watchful waiting and a decrease in active treatment for low-risk PC.

For high-risk disease, there was a decrease in active treatment use over time, while active surveillance and androgen deprivation therapy increased.

RELATED: New Method Helps Identify Neighborhood Factors Associated With Aggressive Prostate Cancer

"Low-risk PC is increasingly being managed with active surveillance, which now accounts for nearly 20 percent of cases, demonstrating the feasibility of limiting overtreatment at the patient and provider level," the authors write. "High-risk PC is being treated less frequently, contrary to level 1 evidence, possibly owing to overtreatment fears incited by the USPSTF."

Reference

  1. Maurice MJ, Kim SP, Abouassaly R, et al. Current Status of Prostate Cancer Diagnosis and Management in the United States. [published online ahead of print June 23, 2016.] JAMA Oncol. doi:10.1001/jamaoncol.2016.1785.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters